index

Labari mai dadi: Iphes ya shiga hannu tare da Jami'ar Pennsylvania don bunkasa sabon kwayoyin halitta!

Kwanan nan, Iphase, a cikin haɗin gwiwar Pervemman Makarantar Magunguna a Jami'ar anthazed Hz -, Nazarin anti-ote ", Nazarin antacce", Nazarin da aka kirkira wani labari ne ya hana halittun. antiby Hz - 1127 kuma ya gwada kusanci da tabbaci, ƙayyadaddiyar da ikon hana tsallake ta.
Mymmemy cympopoetin (Tslp) memba ne naIl - 2 CytokineIyali, da kuma dysrefulation na TSLP - An danganta Tslp na TSLP (TSPR) da aka danganta shi da ci gaban cututtukan da ba na cutar kansa ba, gami da manyan ciwan jini. Sabili da haka, takamaiman da ke daurin TSLP ta amfani da abubuwan rigakafi na dabaru ne don lura da cututtukan rashin lafiyan cuta da cutar kansu. Har yanzu da FDA ya amince da Tezelekumab, anti dan adam - Tslp Monoclonal othlodal, don lura da mummunan asma.
Iphotes ya kirkiro a karon farko a wannan binciken sabon anti na mutum - Tlic - 1127, tare da kusanci da tsari na musamman da zabin. Idan aka kwatanta da Tezelekumab, da epitopes daure a cikin Tslp ta biyu suna da kama sosai, kuma Hz - 1127 yana da ƙarfin ƙarfi don toshe ma'amala tsakanin TSLP da Tsult. HZ - 1127 kuma ta nuna manyan tasirin TECEPELEPEPEPELUB a cikin hanzarta dakatar da cutar slc17 da CCL22 na iya zama mai yuwuwar ƙwayar cuta don cututtukan ƙwayar cuta da cutar kansa da cutar kansa da cutar kansa.
Fasahar haɓakawa ta antibody da ta shiga cikin wannan binciken da kuma abubuwan da suka dace da sunadarai da maganin rigakafi da aka yi amfani da su a cikin gwaje-gwajen da aka bayar.


Fig.1

SiffaPbmcs

Tattalin Injigatic Cread

Lokaci: 2024 - 07 - 07 - 27 - 27 16:34:37
  • A baya:
  • Next:
  • Zabin Harshe